DE69607344D1 - Verfahren zur herstellung von n,n'-disubstituierten cyclischen harnstoffen - Google Patents

Verfahren zur herstellung von n,n'-disubstituierten cyclischen harnstoffen

Info

Publication number
DE69607344D1
DE69607344D1 DE69607344T DE69607344T DE69607344D1 DE 69607344 D1 DE69607344 D1 DE 69607344D1 DE 69607344 T DE69607344 T DE 69607344T DE 69607344 T DE69607344 T DE 69607344T DE 69607344 D1 DE69607344 D1 DE 69607344D1
Authority
DE
Germany
Prior art keywords
producing
cyclic ureas
disubstituted cyclic
disubstituted
ureas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69607344T
Other languages
English (en)
Other versions
DE69607344T2 (de
Inventor
Edgar Smyser
Nicholas Confalone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
DuPont Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co, DuPont Pharmaceuticals Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of DE69607344D1 publication Critical patent/DE69607344D1/de
Publication of DE69607344T2 publication Critical patent/DE69607344T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D323/00Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69607344T 1995-06-06 1996-06-04 Verfahren zur herstellung von n,n'-disubstituierten cyclischen harnstoffen Expired - Fee Related DE69607344T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/469,409 US5532356A (en) 1995-06-06 1995-06-06 Method for preparing N,N'-disubstituted cyclic ureas
PCT/US1996/008556 WO1996039393A1 (en) 1995-06-06 1996-06-04 Method for preparing n, n'-disubstitued cyclic ureas

Publications (2)

Publication Number Publication Date
DE69607344D1 true DE69607344D1 (de) 2000-04-27
DE69607344T2 DE69607344T2 (de) 2000-09-21

Family

ID=23863677

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69607344T Expired - Fee Related DE69607344T2 (de) 1995-06-06 1996-06-04 Verfahren zur herstellung von n,n'-disubstituierten cyclischen harnstoffen

Country Status (20)

Country Link
US (1) US5532356A (de)
EP (1) EP0830349B1 (de)
JP (1) JPH11506765A (de)
AR (1) AR002385A1 (de)
AT (1) ATE190974T1 (de)
AU (1) AU700805B2 (de)
CA (1) CA2222132A1 (de)
DE (1) DE69607344T2 (de)
DK (1) DK0830349T3 (de)
ES (1) ES2145452T3 (de)
GR (1) GR3033199T3 (de)
HR (1) HRP960258B1 (de)
IL (1) IL122457A0 (de)
MX (1) MX9709125A (de)
MY (1) MY113863A (de)
NZ (1) NZ309557A (de)
PT (1) PT830349E (de)
TW (1) TW355707B (de)
WO (1) WO1996039393A1 (de)
ZA (1) ZA964749B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
US6054597A (en) * 1995-11-14 2000-04-25 Dupont Pharmaceuticals Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
WO1998043969A1 (en) * 1997-03-31 1998-10-08 Dupont Pharmaceuticals Company Indazoles of cyclic ureas useful as hiv protease inhibitors
US6218534B1 (en) 1997-10-06 2001-04-17 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
US6313110B1 (en) * 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
US7104279B2 (en) * 2000-05-30 2006-09-12 Red Valve Co., Inc. Method and apparatus for preventing stagnation in fluid reservoirs
FR2810039B1 (fr) * 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation
EP2228369A1 (de) 2003-12-23 2010-09-15 Astex Therapeutics Ltd. Pyrazolderivate als modulatoren von proteinkinase
US8343953B2 (en) * 2005-06-22 2013-01-01 Astex Therapeutics Limited Pharmaceutical compounds
JP5345842B2 (ja) 2005-06-23 2013-11-20 アステックス・セラピューティクス・リミテッド プロテインキナーゼモジュレーターとしてのピラゾール誘導体を含む医薬組み合わせ
US20080033167A1 (en) * 2005-12-29 2008-02-07 Gilles Guichard Compositions and methods for synthesizing heterocyclic therapeutic compounds
GB0704932D0 (en) 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
KR101663255B1 (ko) * 2015-11-30 2016-10-10 주식회사 삼양사 안정성이 향상된 농축 무수당 알코올 제조용 조성물 및 무수당 알코올의 농축 방법
KR101663264B1 (ko) * 2015-11-30 2016-10-10 주식회사 삼양사 저장 안정성이 향상된 무수당 알코올 조성물 및 무수당 알코올의 저장 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
DE69221309T2 (de) * 1991-10-11 1997-12-11 Du Pont Merck Pharma Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer

Also Published As

Publication number Publication date
AR002385A1 (es) 1998-03-11
GR3033199T3 (en) 2000-08-31
DE69607344T2 (de) 2000-09-21
WO1996039393A1 (en) 1996-12-12
US5532356A (en) 1996-07-02
ZA964749B (en) 1997-12-08
PT830349E (pt) 2000-08-31
DK0830349T3 (da) 2000-07-17
TW355707B (en) 1999-04-11
HRP960258A2 (en) 1997-12-31
MY113863A (en) 2002-06-29
ATE190974T1 (de) 2000-04-15
MX9709125A (es) 1998-03-31
EP0830349A1 (de) 1998-03-25
ES2145452T3 (es) 2000-07-01
AU700805B2 (en) 1999-01-14
AU5975296A (en) 1996-12-24
JPH11506765A (ja) 1999-06-15
CA2222132A1 (en) 1996-12-12
HRP960258B1 (en) 2000-12-31
IL122457A0 (en) 1998-06-15
EP0830349B1 (de) 2000-03-22
NZ309557A (en) 2001-06-29

Similar Documents

Publication Publication Date Title
DE69620461T2 (de) Verfahren zur herstellung von 1,1,1,3,3,-pentafluoropropanen
ATE360608T1 (de) Verfahren zur herstellung von 1,3-diolen
DE69618476D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69801489T2 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69512250T2 (de) Verfahren zur herstellung von 1,1,1,3,3,3- hexafluorpropan
ATE190974T1 (de) Verfahren zur herstellung von n,n'- disubstituierten cyclischen harnstoffen
EE9700330A (et) N-üksikasendatud ja N,N'-kaksikasendatud ebasümmeetriliste tsükliliste uureade valmistamise meetod
DE69425496T2 (de) Verfahren zur herstellung von 1,4-dienen
ATA41091A (de) Verfahren zur herstellung von beta-(d)-2',3'-didesoxyinosin
DE69717115D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69603261D1 (de) Verfahren zur herstellung von 1,2-benzisothiazolonen
DE59705787D1 (de) Verfahren zur herstellung von n,n'-dialkylperylen-3,4,9,10-tetracarbonsäurediimiden
ATE366251T1 (de) Verfahren zur herstellung von 1,3- disubstituierten-4-oxocyclischen harnstoffen
ATE187959T1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE69621628T2 (de) Verfahren zur herstellung von ammoxidationskatalysatoren
DE59510636D1 (de) Verfahren zur herstellung von 8-alpha,12-oxido-13,14,15,16-tetranorlabdan
DE69711039D1 (de) Verfahren zur herstellung von 1,3-alkandiolen
DE69631154D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
ATE275563T1 (de) Verfahren zur herstellung von 1,3- disubstituierten-4-oxocyclischen harnstoffen
DE69418723D1 (de) Verfahren zur herstellung von 1,1,2,3,3-pentafluorpropan
DE58902684D1 (de) Verfahren zur herstellung von cyclischen n,n'-dimethylharnstoffen.
ATE208368T1 (de) Verfahren zur herstellung von 3,4 disubstituirten dinitroanilinen
DE59603908D1 (de) Verfahren zur Herstellung von N',N'-disubstituierten 1,4-Diaminoanthrachinonen
DE69410898D1 (de) Verfahren zur herstellung von n,n,-disubstituiertem aminophenol
DE69604808D1 (de) Verfahren zur herstellung von alpha,omega-bromochloroalkanen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BRISTOL-MYERS SQUIBB PHARMA CO., PRINCETON, N.J.,

8339 Ceased/non-payment of the annual fee